The market is putting up a strong performance this year with the S 500 gaining 16% as of this writing. That's a far cry from what we saw for most of 2022 when equities experienced a painful downturn. But while things are looking up for many stocks, some are still struggling under the weight of company-specific issues.

That's the case with CVS Health (NYSE: CVS) and (NASDAQ: ETSY). Both companies are trading near their 52-week lows, but both are worth buying, at least for long-term investors. Here's why. 

CVS Health has encountered several issues this year. First, the company's financial results have failed to impress investors. In the second quarter, sales grew by 10.3% year over year to $88.9 billion. However, the company's adjusted earnings per share dropped to $2.21, down from the $2.53 reported in the year-ago period.

Continue reading

Source Fool.com